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   Peripheral	  arterial	  occlusive	  disease	  (PAOD)	  affects	  approximately	  200	  million	  
individuals	  globally.	  The	  major	  underlying	  cause	  of	  PAOD	  is	  an	  inflammatory	  disease	  known	  as	  
atherosclerosis,	  which	  results	  from	  the	  build-­‐up	  of	  low-­‐density	  lipoproteins	  (LDL)	  in	  the	  sub-­‐
intimal	  space.	  This	  initiates	  a	  complex	  cascade	  of	  events	  that	  lead	  to	  plaque	  growth.	  Plaque	  
growth	  can	  then	  expand	  into	  the	  lumen	  of	  the	  vessel	  and	  result	  in	  occlusion	  and/or	  thrombosis.	  
Symptoms	  of	  the	  disease	  can	  include	  claudication,	  ulcers,	  and/or	  gangrene,	  although	  many	  
patients	  are	  asymptomatic.	  Similar	  to	  other	  forms	  of	  ischemic	  disease,	  risk	  factors	  for	  PAOD	  
include	  hypertension,	  diabetes,	  and	  smoking.	  Common	  treatments	  include	  life	  style	  changes,	  
antiplatelet	  therapies,	  and	  endovascular	  and	  surgical	  revascularization.	  Natural	  bypass	  surgery	  is	  
a	  common	  revascularization	  method	  for	  patients	  suffering	  from	  advanced	  stages	  of	  PAOD.	  	  In	  
this	  procedure	  an	  autologous	  vein	  segment	  is	  grafted	  to	  bypass	  a	  section	  of	  occluded	  artery.	  
However,	  many	  patients	  experience	  restenosis	  or	  are	  unable	  to	  undergo	  such	  an	  invasive	  
procedure.	  New	  therapies	  are	  needed	  to	  bridge	  this	  gap	  in	  patient	  care.	  A	  natural	  bypass	  is	  a	  
healing	  mechanism	  that	  takes	  advantage	  of	  pre-­‐existing	  vessels	  by	  enlarging	  them	  to	  
compensate	  for	  occluded	  flow	  in	  another	  vessel.	  The	  extent	  to	  which	  these	  natural	  bypasses	  can	  
restore	  the	  original	  flow	  rate	  seems	  to	  be	  predicated	  on	  the	  vascular	  network	  topology	  of	  an	  
individual.	  Animal	  studies	  indicate	  that	  microvascular	  topologies	  can	  be	  either	  protective	  or	  
vulnerable	  to	  ischemic	  insult	  from	  ischemic	  diseases,	  such	  as	  PAOD.	  Mice	  with	  highly	  
interconnected	  (anastomotic)	  vessel	  networks	  experience	  faster	  recovery	  times	  than	  those	  with	  
branching	  tree	  –like	  	  (dendritic)	  structures,	  likely	  due	  to	  compensation	  mechanisms	  from	  
redundant	  supply	  vessels.	  Balb/C	  mice	  mimic	  dendritic	  architecture	  and	  experience	  greater	  
ischemia	  and	  reduced	  hind	  limb	  functionality	  compared	  with	  C57BL/6	  mice,	  which	  are	  the	  
anastomotic	  archetype,	  following	  hind	  limb	  femoral	  artery	  ligation.	  The	  presence	  of	  collateral	  
vessels	  in	  the	  gracilis	  of	  Balb/C	  mice,	  observed	  in	  previous	  work	  and	  confirmed	  in	  this	  study	  
provides	  evidence	  that	  preexisting	  collaterals	  alone	  are	  not	  sufficient	  for	  improving	  flow.	  
Evaluating	  the	  ability	  of	  the	  gracilis	  collateral	  to	  re-­‐perfuse	  the	  distal	  hindlimb	  would	  require	  
perfusion	  labeling	  of	  the	  endothelium,	  such	  as	  with	  lectin.	  The	  technique	  for	  perfusion	  labeling	  
the	  gracilis	  muscle	  was	  demonstrated	  in	  this	  study.	  Promising	  results	  were	  obtained,	  however	  
further	  optimization	  will	  be	  needed	  to	  improve	  consistency	  of	  the	  labeling.	  These	  findings	  
suggest	  further	  investigation	  into	  both	  the	  nature	  of	  impaired	  collateral	  remodeling,	  and	  the	  
continued	  optimization	  of	  the	  of	  lectin	  perfusion	  labeling	  to	  asses	  re-­‐perfusion	  following	  arterial	  
occlusion.	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   Peripheral	  Artery	  Disease	  (PAOD)	  is	  broadly	  defined	  as	  the	  impaired	  function	  and/or	  
structure	  of	  noncoronary	  arteries	  and	  it	  affects	  27	  million	  people	  in	  Western	  Europe	  and	  North	  
America	  [3,7].	  Clinical	  manifestations	  of	  PAOD	  include	  claudication,	  impaired	  mobility,	  ischemic	  
pain	  at	  rest,	  and/or	  impaired	  wound	  recovery,	  although	  many	  patients	  with	  PAOD	  may	  be	  
asymptomatic	  [3,	  7,	  2].	  These	  symptoms	  are	  associated	  with	  decreased	  quality	  of	  life,	  limb	  
amputations,	  and	  an	  increased	  risk	  of	  death	  because	  PAOD	  is	  generally	  an	  indicator	  of	  systemic	  
atherosclerosis	  [1].	  This	  paper	  will	  focus	  on	  the	  current	  understanding	  of	  PAOD,	  including	  its	  
pathophysiology,	  current	  treatments,	  and	  novel	  research	  to	  improve	  patient	  therapies.	  
	   Atherosclerosis	  is	  a	  chronic	  disease	  of	  the	  artery	  wall	  that	  results	  in	  the	  formation	  of	  
subintimal	  atheromatous	  lesions	  that	  can	  reduce	  lumen	  diameter	  and	  decrease	  or	  stop	  blood	  
flow	  [4].	  Conditions	  such	  as	  hypertension,	  which	  cause	  damage	  to	  the	  arterial	  wall,	  alone	  or	  in	  
combination	  with	  turbulent	  sheer	  stress	  seen	  at	  arterial	  bifurcations,	  activates	  the	  endothelial	  
layer	  to	  allow	  increased	  migration	  and	  retention	  of	  low-­‐density	  lipoproteins	  (LDLs)	  into	  
subintimal	  area	  [4].	  The	  activated	  endothelial	  cells	  also	  present	  adhesion	  proteins	  that	  bind	  
leukocytes,	  which	  extravasate	  into	  the	  subintimal	  area	  [4].	  Extravasated	  monocytes	  transform	  
into	  macrophages,	  which	  phagocytose	  LDL	  particles	  and	  eventually	  become	  foam	  cells	  [4].	  This	  
process	  initiates	  a	  positive	  feedback	  loop	  of	  inflammation	  that	  results	  in	  a	  fatty	  plaque	  build	  up.	  
This	  build-­‐up	  can	  result	  in	  obstruction	  of	  flow	  via	  stenosis	  and/or	  initiation	  of	  thrombi	  that	  
blocks	  flow	  at	  or	  downstream	  of	  the	  plaque	  site	  [4].	  The	  obstructed	  flow	  reduces	  nutrient	  
delivery	  to	  tissue	  downstream,	  causing	  ischemia	  and/or	  cell	  death	  [4].	  
	   Diagnosising	  PAOD	  in	  patients	  is	  challenged	  by	  the	  lack	  of	  clinical	  presentation,	  making	  
it	  difficult	  to	  identify	  at-­‐risk	  patients	  [5].	  One	  of	  the	  few	  easily	  identifiable	  symptoms	  is	  
intermittent	  claudication,	  which	  is	  seen	  in	  conjunction	  with	  peripheral	  artery	  disease	  in	  20-­‐40%	  
of	  patients	  [6].	  Risk	  factors	  for	  the	  disease	  include:	  smoking,	  diabetes,	  hypertension,	  and	  
hyperlipidemia	  [3,	  7].	  For	  at-­‐risk	  patients	  and	  those	  over	  the	  age	  of	  50,	  a	  non-­‐invasive	  
measurement	  known	  as	  the	  ankle-­‐brachial	  pressure	  index	  (ABPI)	  test	  is	  administered	  to	  detect	  
PAOD	  [6].	  The	  ABPI	  is	  calculated	  by	  measuring	  the	  systolic	  blood	  pressure	  in	  the	  arterial	  vessels	  
of	  the	  ankle,	  and	  dividing	  it	  by	  a	  measurement	  of	  the	  systolic	  pressure	  of	  the	  brachial	  artery.	  
ABPI	  values	  range	  from	  healthy,	  anything	  greater	  than	  1,	  to	  moderate	  disease,	  0.5-­‐0.80,	  to	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critical	  ischemia,	  which	  is	  anything	  less	  than	  0.30	  [5].	  	  Preventative/interventional	  lifestyle	  
changes	  are	  recommended	  for	  patients	  with	  or	  at	  risk	  for	  disease.	  These	  changes	  can	  include	  
exercise	  programs,	  cholesterol	  management	  drugs,	  smoking	  cessation,	  and	  anti-­‐platelet	  
therapies	  [6].	  	  
	   Advanced	  cases	  of	  PAOD,	  such	  as	  in	  the	  case	  of	  critical	  limb	  ischemia	  (CLI),	  may	  require	  
revascularization	  procedures.	  These	  can	  include	  endovascular	  treatments	  and	  surgical	  
revascularization	  [7].	  Endovascular	  procedures	  are	  widely	  used	  as	  a	  first	  line	  of	  treatment,	  as	  
percutaneous	  procedures	  involve	  less	  risk	  than	  surgical	  revascularization	  and	  can	  achieve	  limb	  
salvage	  and	  viability	  [8].	  Surgical	  revascularization	  is	  used	  for	  patients	  with	  extensive	  foot	  
infections,	  tissue	  loss,	  or	  gangrene.	  These	  more	  advanced	  symptoms	  call	  for	  surgical	  
revascularization	  because	  it	  can	  increase	  blood	  flow	  to	  the	  limb	  and	  allows	  for	  more	  intensive	  
treatment,	  if	  necessary.	  Many	  of	  these	  patients	  however,	  are	  unable	  to	  receive	  treatment	  using	  
traditional	  methods.	  These	  patients	  may	  be	  unable	  to	  sustain	  the	  rigors	  of	  surgery,	  lack	  of	  
suitable	  vessels	  for	  use,	  or	  develop	  restenosis	  following	  a	  procedure	  [9].	  Thus,	  there	  is	  a	  need	  
for	  treatments	  that	  prevent	  and	  ameliorate	  symptoms	  resulting	  from	  PAOD,	  such	  as	  by	  
promoting	  natural	  healing	  mechanisms	  and	  understanding	  genetic	  predispositions	  that	  affect	  
the	  body’s	  ability	  to	  recover	  from	  an	  occlusion.	  	  
	   Natural	  healing	  mechanisms,	  or	  endogenous	  vascularization,	  can	  be	  broken	  into	  
angiogenesis	  and	  arteriogenesis.	  Angiogenesis	  is	  the	  sprouting	  of	  new	  capillaries	  from	  pre-­‐
existing	  vessels	  and	  results	  in	  the	  formation	  of	  new	  capillary	  networks	  [10].	  It	  occurs	  during	  
embryonic	  development	  and	  wound	  healing	  to	  supply	  tissue	  with	  necessary	  nutrients	  [11].	  
Initial	  attempts	  at	  reperfusing	  tissue	  through	  endogenous	  revascularization	  focused	  on	  
stimulating	  angiogenesis,	  however	  clinical	  trials	  for	  these	  treatments	  have	  shown	  limited	  
efficacy	  [18–20].	  In	  light	  of	  these	  findings,	  emerging	  efforts	  have	  focused	  on	  arteriogenesis	  as	  an	  
alternative	  method	  for	  restoring	  blood	  flow.	  Arteriogenesis	  describes	  the	  growth	  of	  functional	  





Figure	  1.	  Enlargement	  of	  collateral	  vessels	  following	  occlusion	  of	  artery.	  The	  collateral	  vessels	  (smaller	  vessels	  perpendicular	  to	  arteries)	  undergo	  arteriogenesis	  	  in	  response	  to	  increased	  flow	  and	  shear	  stress.	  This	  enlarges	  the	  vessels	  and	  helps	  restore	  flow	  to	  the	  occluded	  artery	  [10].	  
	   Experimental	  data	  indicates	  that	  the	  driving	  force	  for	  arteriogenesis	  is	  shear	  stress	  [9].	  
The	  increased	  shear	  stress	  initiates	  a	  cascade	  of	  events	  that	  leads	  to	  increased	  vessel	  lumen	  
diameter	  and	  wall	  thickness	  [10].	  This	  means	  that	  unlike	  angiogenesis,	  which	  is	  stimulated	  by	  
hypoxia,	  arteriogenesis	  can	  occur	  in	  the	  absence	  of	  hypoxic	  tissue.	  The	  reason	  why	  
arteriogenesis	  is	  so	  effective	  at	  restoring	  flow	  can	  be	  seen	  by	  examining	  the	  Hagen-­‐Poiseuille	  
Equation,	  Equation	  2.	  Holding	  all	  other	  variables	  constant	  the	  flow	  rate,	  Q,	  is	  dependent	  on	  the	  
radius	  raised	  to	  the	  fourth	  power,	  meaning	  that	  even	  small	  increases	  in	  diameter	  can	  lead	  to	  
large	  increases	  in	  flow	  rate.	  Both	  experimental	  and	  theoretical	  data	  indicate	  that	  arteriogenesis	  
can	  play	  an	  important	  role	  in	  restoring	  flow	  in	  tissue	  following	  an	  occlusive	  event.	  




	   Recent	  efforts	  have	  focused	  on	  characterizing	  vascular	  network’s	  acute	  and	  chronic	  
responses	  to	  ischemic	  injury,	  to	  construct	  a	  model	  for	  natural	  healing	  mechanisms	  that	  accounts	  
for	  both	  the	  role	  of	  both	  the	  physical	  network	  structure	  and	  the	  network’s	  ability	  to	  adapt	  over	  
time	  [14-­‐15].	  These	  networks	  are	  the	  transportation	  routes	  through	  which	  blood	  delivers	  
oxygen	  and	  nutrients	  to	  tissue.	  Depending	  on	  the	  layout	  of	  these	  vascular	  networks,	  they	  can	  
either	  be	  highly	  susceptible	  to	  tissue	  damage	  resulting	  from	  occlusions,	  or	  protected	  against	  it	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[14-­‐15].	  Depending	  on	  the	  severity	  of	  the	  occlusion,	  symptoms	  can	  range	  from	  greater	  fatigue	  to	  
necrosis	  and	  loss	  of	  limbs	  [1].	  There	  is	  a	  strong	  interest	  in	  developing	  therapies	  that	  take	  
adavantage	  of	  natural	  healing	  mechanisms	  for	  patients	  unable	  to	  undergo	  traditional	  and	  more	  
invasive	  treatment	  options.	  
	   A	  spectrum	  of	  vessel	  network	  architectures	  has	  been	  identified	  in	  animal	  models	  of	  
chronic	  ischemia,	  ranging	  from	  heavily	  ramified	  arcades	  to	  unconnected	  dendritic	  trees,	  Figure	  2	  
[14].	  Animals	  with	  heavily	  ramified	  arcades	  show	  faster	  recovery	  rates	  and	  decreased	  tissue	  
damage	  in	  response	  to	  ischemic	  insult	  [14-­‐15].	  Collateral	  vessels	  play	  a	  key	  role	  in	  this	  recovery	  	  
by	  remodeling	  in	  response	  to	  an	  occlusion	  and	  mitigating	  loss	  of	  blood	  flow	  [9,	  14,	  15].	  The	  
collateral	  vessels	  undergo	  arteriogenesis,	  which	  increases	  diameter	  and	  the	  number	  of	  smooth	  
muscle	  cells	  surrounding	  the	  vessel,	  allowing	  for	  an	  increase	  in	  flow	  through	  the	  vessel	  and	  
greater	  control	  of	  the	  flow	  through	  it.	  Understanding	  of	  how	  these	  vessel’s	  location,	  density,	  
and	  adaptability	  over	  time	  affect	  recovery	  is	  still	  being	  investigated.	  
	   Models	  of	  the	  extreme	  ends	  of	  the	  vascular	  network	  spectrum	  are	  used	  to	  study	  the	  
role	  of	  collateral	  networks	  in	  recovery	  from	  ischemic	  insult.	  Two	  strains	  of	  mice	  that	  represent	  
opposing	  ends	  of	  the	  spectrum	  in	  the	  spinotrapezius	  are	  the	  Balb/C	  and	  C57Bl/6.	  Balb/C	  mice	  
exhibit	  dendritic	  network	  architecture,	  Figure	  3B;	  whereas	  C57Bl/6	  mice	  have	  heavily	  ramified	  
networks,	  Figure	  3A	  [14].	  This	  difference	  in	  network	  topology	  plays	  a	  critical	  role	  in	  susceptibility	  
to	  ischemic	  insult,	  because	  arteriole-­‐to-­‐arteriole	  connections	  provide	  a	  measurement	  of	  how	  
well	  flow	  can	  be	  re-­‐directed	  around	  an	  occlusion	  [15].	  Balb/C	  mice	  show	  little	  to	  no	  
interconnection	  between	  arterioles	  feeding	  different	  sections	  of	  tissue,	  Figure	  3A.	  For	  Balb/C	  
mice,	  reperfusion	  of	  these	  sections	  of	  tissue	  was	  coincident	  with	  the	  transformation	  of	  
capillaries	  into	  arterioles,	  which	  allowed	  increased	  flow	  from	  adjacent	  arteriolar	  trees	  to	  reach	  
the	  section	  of	  tissue	  with	  restricted	  flow	  [14].	  The	  vessels	  were	  presumed	  to	  be	  pre-­‐existing	  
capillaries	  undergoing	  arteriogenesis,	  thus	  supporting	  the	  hypothesis	  that	  pre-­‐existing	  collateral	  




Figure	  2.	  Differences	  between	  Balb/C	  and	  C57	  network	  topologies.	  	  Adapted	  from	  Gabhann	  et	  al.	  
Arteriolar	  and	  venular	  networks	  in	  mouse	  spinotrapezius	  muscle.	  C57Bl/6	  shown	  on	  the	  left	  
exhibits	  highly	  interconnected	  network.	  Balb/C	  on	  the	  right	  shows	  highly	  dendritic	  arbor	  with	  
little	  to	  no	  interconnections	  [reference	  number].	  
	   	  
Our	  collaborators	  have	  used	  the	  spinotrapezius	  arteriolar	  ligation	  model	  because	  it	  is	  superficial	  
and	  can	  be	  whole-­‐mounted	  for	  imaging	  using	  confocal	  microscopy	  [14].	  In	  addition	  to	  the	  
arterial	  ligation	  model	  in	  the	  spinotrapezius,	  the	  hind	  limb	  femoral	  artery	  ligation	  model	  is	  used	  
to	  investigate	  the	  affects	  of	  collateral	  density	  on	  flow	  recovery	  [15].	  The	  hind	  limb	  ligation	  
model	  simulates	  a	  complete	  occlusion	  of	  the	  femoral	  artery,	  blocking	  downstream	  flow	  and	  
forcing	  blood	  to	  travel	  through	  a	  collateral	  circuit	  to	  reach	  ischemic	  areas.	  Balb/C	  mice	  have	  
fewer	  collateral	  vessels	  in	  the	  hind	  limb	  compared	  to	  C57s,	  a	  difference	  that	  persists	  for	  at	  least	  
21	  days	  following	  femoral	  artery	  ligation	  [15].	  	  This	  suggests	  Balb/C	  mice	  have	  a	  reduced	  
capacity	  to	  remodel	  in	  response	  to	  increased	  flow.	  Strikingly,	  unlike	  in	  the	  spinotrapezius	  model,	  
the	  gracilis	  muscle	  of	  Balb/C	  mice	  contains	  a	  collateral	  arteriole,	  yet	  downstream	  flow	  still	  
remains	  impaired	  21	  days	  following	  femoral	  artery	  ligation	  [15].	  This	  pilot	  study	  was	  designed	  to	  
both	  validate	  previous	  findings	  and	  optimize	  a	  lectin	  perfusion	  stain	  protocol,	  both	  of	  which	  will	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be	  used	  to	  further	  understand	  the	  role	  collateral	  networks	  in	  chronic	  flow	  regulation.	  These	  
findings	  will	  hopefully	  translate	  into	  therapies	  that	  fill	  the	  gap	  in	  care	  for	  many	  patients	  suffering	  
from	  PAOD.	  	  
Specific	  Aims	  and	  Hypothesis	  
	  
	   This	  first	  study	  in	  this	  project	  was	  designed	  to	  validate	  the	  existence	  of	  collateral	  vessels	  
in	  the	  gracilis	  muscle.	  	  
Specifc	  Aim	  1:	  To	  test	  the	  hypothesis	  that	  collateral	  arterioles	  are	  present	  in	  the	  gracilis	  muscle	  
of	  Balb/C	  mice.	  The	  purpose	  of	  this	  aim	  is	  to	  validate	  previous	  research	  and	  begin	  answering	  the	  
questions	  of	  whether	  the	  spinotrapezius	  muscle	  and	  gracilis	  muscle	  exhibit	  different	  network	  
topologies,	  whether	  network	  architecture	  is	  a	  limiting	  factor	  in	  flow	  recovery,	  and	  whether	  
network	  remodeling	  is	  impaired	  or	  delayed	  compared	  to	  other	  strains	  of	  mice.	  
	   This	  second	  study	  in	  this	  project	  was	  designed	  to	  optimize	  the	  lectin	  perfusion	  stain	  for	  
use	  in	  the	  MAVR	  lab.	  
Specific	  Aim	  2:	  To	  test	  the	  efficacy	  of	  lectin	  perfusion	  stain	  in	  spinotrapezius	  for	  use	  as	  a	  visual	  
indicator	  of	  perfused	  tissue	  regions.	  The	  purpose	  of	  this	  aim	  is	  to	  develop	  a	  visual	  method	  of	  
identifying	  perfused	  regions	  of	  tissue.	  This	  would	  enable	  researchers	  to	  study	  recovery	  from	  
perfusion	  deficits	  over	  time,	  by	  comparing	  perfusion	  of	  muscles	  at	  different	  time	  points	  
following	  an	  occlusive	  event.	  This	  can	  be	  adapted	  to	  the	  hind-­‐limb	  ligation	  model	  in	  the	  gracilis	  









Animal	  Housing	  and	  Care	  
	  
	   Male	  Balb/C	  mice	  from	  Taconic	  Farms	  aged	  seven	  to	  nine	  weeks	  were	  used	  for	  all	  
experiments	  according	  to	  protocols	  reviewed	  and	  approved	  by	  the	  California	  Polytechnic	  State	  
University	  Institutional	  Animal	  Care	  and	  Use	  Committee.	  Mice	  were	  housed	  in	  a	  temperature-­‐
controlled	  room	  with	  12-­‐hour	  light	  and	  dark	  cycles.	  Mice	  were	  checked	  daily	  to	  ensure	  proper	  
food	  and	  water	  levels,	  which	  were	  administered	  ad	  libitum.	  	  Cages	  housed	  2-­‐4	  mice	  with	  
bedding	  and	  enrichment	  devices	  and	  were	  changed	  weekly	  to	  ensure	  a	  clean	  environment.	  	  
Femoral	  Artery	  Ligation	  
	   The	  mice	  were	  anesthetized	  with	  isofluorine	  (1-­‐2%	  flowing	  at	  0.5-­‐1.0	  l⋅min-­‐1).	  Hair	  
around	  incision	  site	  was	  removed	  with	  depilatory	  cream	  and	  disinfected	  with	  Nolvasan.	  A	  
subcutaneous	  injection	  of	  buprenorphrine	  (0.075	  mg⋅kg-­‐1)	  was	  then	  administered	  as	  an	  
analgesic.	  The	  temperature	  of	  the	  mice	  was	  maintained	  at	  35±	  1.0	  °	  C	  throughout	  the	  procedure	  
using	  a	  rectal-­‐temperature	  controlled	  heating	  pad.	  	  
	   A	  skin	  incision	  was	  made	  in	  the	  medial	  aspect	  of	  the	  thigh	  and	  extended	  cranially	  and	  
medially	  along	  femoral	  artery	  until	  the	  abdominal	  wall.	  Blunt	  dissection	  was	  used	  to	  remove	  
connective	  tissue	  and	  expose	  the	  neurovascular	  bundle.	  The	  epigastric	  fat	  pad	  superficial	  the	  
profunda	  femoris	  artery	  was	  removed	  and	  the	  epigastric	  artery-­‐vein	  pair	  cauterized.	  The	  
femoral	  artery	  was	  separated	  from	  the	  vein	  and	  nerve,	  then	  ligated	  downstream	  of	  the	  
profunda	  femoris	  artery	  and	  upstream	  of	  the	  popliteal	  branch	  using	  6-­‐0	  silk	  suture.	  Sterile	  saline	  
was	  used	  throughout	  the	  procedure	  to	  irrigate	  the	  tissue	  and	  prevent	  muscle	  desiccation.	  	  
Lectin	  Perfusion	  Labeling	   	  
	   To	  visualize	  perfused	  regions	  of	  vasculature	  in	  the	  gracilis	  muscle,	  fluorescently	  labeled	  
lectin	  was	  injected	  into	  anesthetized	  mice.	  The	  jugular	  vein	  of	  the	  mice	  was	  exposed	  and	  250uL	  
of	  lectin-­‐PBS	  solution	  (concentration:	  0.1mg/mL;	  25ug	  lectin)	  was	  slowly	  injected	  using	  a	  27-­‐
gauge	  insulin	  syringe.	  Pressure	  was	  briefly	  applied	  to	  the	  vein	  following	  withdrawal	  using	  a	  
cotton	  swab	  to	  prevent	  hemorrhage.	  	  
14	  
	  
Harvesting	  of	  Wholemount	  tissues:	  
	   The	  ipsilateral	  and	  contralateral	  gracilis	  anterior	  muscles	  were	  perfusion	  fixated	  (4%-­‐
paraformaldehyde	  solution),	  stripped	  of	  fascia,	  undermined,	  excised,	  and	  post-­‐fixed	  overnight	  at	  
4	  °C.	  The	  muscles	  were	  then	  rinsed	  and	  stored	  in	  PBS.	  
Alpha	  Smooth	  Muscle	  Actin	  Stain	  
	   To	  visualize	  arteriolar	  network	  structure	  of	  the	  muscle,	  alpha	  smooth	  muscle	  actin	  
(ASMA)	  was	  stained.	  Muscles	  were	  removed	  and	  placed	  in	  a	  24-­‐well	  culture	  plates.	  The	  muscles	  
were	  incubated	  for	  72	  hours	  in	  a	  solution	  of	  1:200	  1A4	  clone	  (alpha-­‐smooth	  muscle	  actin	  
antibody	  conjugated	  to	  Cy3;	  Sigma,	  St.	  Louis,	  MO)	  in	  0.1%	  saponin	  (reconstituted	  in	  PBS)	  and	  2%	  
BSA	  (reconstituted	  in	  PBS).	  The	  muscles	  were	  then	  washed	  in	  0.1%	  saponin	  (reconstituted	  in	  
PBS)	  3x	  for	  20	  minutes.	  Following	  this,	  a	  final	  wash	  in	  PBS	  for	  30	  minutes	  was	  performed.	  The	  
muscles	  were	  then	  whole	  mounted	  on	  a	  glass	  slides	  in	  a	  solution	  of	  50/50	  PBS	  and	  Glycerol,	  and	  
then	  sealed	  with	  a	  coverslip	  using	  clear	  nail	  polish.	  	  
Imaging	  
	   All	  muscles	  were	  imaged	  using	  an	  Olympus	  FluoView	  confocal	  microscope,	  Figure	  3.	  For	  
optimal	  resolution,	  individual	  sections	  of	  the	  muscle	  were	  imaged	  and	  then	  merged	  to	  provide	  a	  
whole-­‐network	  view.	  For	  the	  ASMA	  stains,	  the	  collateral	  vessels	  were	  then	  examined	  and	  traced	  
using	  the	  GNU	  Image	  Manipulation	  Program	  (GIMP).	  More	  detailed	  information	  available	  in	  
Appendix	  C.	  
	  
Figure	  3.	  A	  layout	  of	  the	  confocal	  microscope.	  Microscope	  set-­‐up	  showing	  the	  imaging	  






	   To	  test	  the	  hypothesis	  that	  collateral	  vessels	  were	  not	  present	  in	  the	  gracilis	  anterior	  of	  
Balb/C	  mice,	  the	  muscles	  from	  three	  mice	  were	  resected	  and	  stained	  following	  a	  unilateral	  
femoral	  artery	  ligation.	  From	  the	  three	  ligated	  mice,	  one	  replicate	  was	  labeled	  as	  a	  poor	  stain	  
and	  excluded	  from	  the	  analysis.	  The	  collateral	  network	  of	  each	  gracilis	  muscle	  was	  analyzed	  by	  
hand	  to	  determine	  whether	  a	  collateral	  vessel	  connected	  the	  profunda	  artery	  and	  saphenous	  






Figure	  4.	  ASMA	  stain	  of	  gracilis	  collateral	  network.	  A)	  A	  representative	  image	  of	  a	  Balb/C	  
collateral	  network	  in	  the	  gracilis	  anterior,	  a	  vessel	  spanning	  the	  entire	  muscle	  is	  shown	  above.	  B)	  
Enlarged	  view	  of	  vessel	  branching	  off	  of	  the	  Profunda.	  C)	  Midzone	  of	  view	  of	  muscle.	  D)	  Reentry	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   Mapping	  the	  network	  architecture	  lays	  the	  foundation	  for	  understanding	  changes	  in	  the	  
vasculature	  over	  time.	  Measuring	  the	  perfusion	  of	  blood	  throughout	  the	  muscle	  under	  changing	  
conditions,	  such	  as	  at	  rest	  and	  following	  an	  ischemic	  insult,	  is	  one	  of	  the	  next	  areas	  of	  
investigation.	  The	  lectin	  perfusion	  stain	  performed	  as	  a	  first-­‐step	  towards	  this	  goal.	  Adapting	  the	  
lectin	  perfusion	  stain	  for	  use	  in	  the	  gracilis	  required	  first	  demonstrating	  success	  in	  replicating	  
the	  previously-­‐established	  protocol	  for	  perfusion	  imaging	  of	  the	  spinotrapezius.	  Shown	  is	  a	  
section	  of	  spinotrapezius	  muscle	  that	  has	  been	  stained	  using	  the	  lectin	  perfusion	  technique,	  
Figure	  5.	  	  
	  
Figure	  5.	  Lectin	  perfusion	  stain	  of	  a	  section	  of	  the	  spinotrapezius	  muscle.	  The	  image	  above	  






	   PAOD	  is	  a	  worldwide	  disease	  affecting	  200	  million	  people	  and	  treatment	  options	  
available	  to	  patients	  unable	  to	  undergo	  conventional	  surgical	  and	  endovascular	  treatments	  are	  
limited	  [16,	  17].	  	  Therapies	  that	  stimulate	  the	  body’s	  natural	  healing	  mechanisms	  are	  now	  being	  
pursued	  to	  meet	  this	  need.	  Arteriogenesis	  plays	  a	  significant	  role	  in	  chronic	  regulation	  of	  the	  
blood	  flow	  throughout	  the	  body	  and	  is	  a	  target	  for	  potential	  therapies	  [9,	  12,	  22].	  Animal	  studies	  
indicate	  that	  vascular	  network	  morphology	  may	  play	  a	  role	  in	  both	  the	  recovery	  time	  and	  
effectiveness	  of	  innate	  arteriogenic	  healing	  response	  following	  an	  occlusion	  [12-­‐13].	  A	  notable	  
example	  of	  this	  can	  be	  seen	  in	  the	  different	  recovery	  times	  experienced	  by	  Balb/C	  and	  C57	  
strains	  of	  mice	  following	  arterial	  ligation	  in	  the	  spinotrapezius	  and	  hind	  limb	  [12-­‐13].	  In	  the	  
spinotrapezius,	  there	  are	  distinct	  differences	  in	  network	  topology	  between	  Balb/C	  and	  C57	  
strains	  of	  mice,	  in	  which	  the	  Balb/C	  mice	  exhibit	  highly	  dendritic	  network	  while	  the	  C57	  has	  a	  
heavily	  ramified	  structure	  [14].	  Collateral	  vessels	  are	  more	  prevalent	  in	  the	  hind	  limb,	  however	  
there	  are	  35%	  fewer	  collaterals	  in	  the	  Balb/C	  as	  compared	  to	  the	  C57	  [15].	  In	  the	  spinotrapezius,	  
immediately	  following	  arterial	  ligation	  of	  feed	  arteries	  supplying	  of	  dendritic	  microvascular	  
networks,	  the	  arterial	  tree	  downstream	  of	  blocked	  feed	  arteries	  was	  not	  perfused,	  indicating	  no	  
collaterals	  were	  present	  [14].	  This	  model	  seems	  to	  explain	  the	  increased	  recovery	  time	  and	  
decreased	  perfusion	  rates	  seen	  in	  the	  Balb/C	  versus	  the	  C57.	  However,	  the	  hindlimb	  also	  
exhibited	  decreased	  perfusion	  and	  increased	  recovery	  time,	  despite	  the	  presence	  of	  collateral	  
vessels	  in	  the	  gracilis	  muscle	  of	  Balb/C	  mice,	  indicating	  other	  factors	  other	  than	  the	  presence	  of	  
collateral	  vessels	  may	  influence	  recovery.	  
	   Preliminary	  results	  confirm	  the	  existence	  of	  a	  collateral	  network	  in	  the	  Balb/C	  gracilis	  
muscle	  as	  reported	  previously	  [15].	  This	  supports	  the	  hypothesis	  that	  vascular	  remodeling	  is	  
either	  impaired	  or	  delayed	  in	  Balb/C	  mice.	  Based	  upon	  this	  conclusion,	  there	  are	  multiple	  
divergent	  lines	  of	  inquiry	  that	  arise.	  The	  first	  question	  stems	  from	  the	  time	  points	  used	  by	  Faber	  
et	  al.	  The	  longest	  time	  point	  measured	  was	  21	  days	  following	  ligation,	  at	  which	  point	  the	  
diameter	  of	  vessels	  in	  the	  collateral	  midzone	  of	  C57	  mice	  had	  increased	  143%	  compared	  to	  
baseline	  versus	  the	  Balb/C	  mice	  that	  only	  experienced	  a	  70%	  increase	  [15].	  If	  there	  is	  a	  delayed	  
response	  in	  Balb/C	  mice,	  then	  a	  later	  time	  point,	  such	  as	  35	  days,	  may	  show	  Balb/C	  mice	  with	  
similar	  vessels	  diameters.	  It	  is	  also	  possible	  that	  the	  arteriogenesis	  process	  is	  fundamentally	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impaired.	  The	  increase	  in	  diameter	  of	  vessels	  as	  compared	  to	  baseline	  indicates	  that	  
arteriogenesis	  is	  occurring,	  however	  one	  or	  more	  of	  the	  signaling	  factors	  may	  be	  defective	  in	  
this	  process.	  	  Examining	  monocyte	  recruitment	  following	  femoral	  artery	  ligation	  would	  be	  one	  
place	  to	  begin	  investigating.	  Monocytes	  are	  important	  in	  the	  artiogenic	  process	  because	  after	  
being	  recruited	  into	  the	  collateral	  wall,	  they	  mature	  into	  macrophages,	  which	  play	  a	  pivotal	  role	  
in	  the	  vascular	  remodeling	  response	  [10].	  Staining	  for	  the	  presence	  of	  these	  cells	  following	  
femoral	  artery	  ligation	  would	  provide	  confirmation	  that	  either	  monocytes	  are	  not	  present,	  and	  
therefore	  cannot	  initiate	  the	  arteriogenic	  process,	  or	  if	  they	  are,	  that	  cell	  signaling	  downstream	  
of	  the	  monocytes	  may	  be	  impaired.	  While	  impaired	  arteriogenesis	  may	  play	  a	  role	  in	  the	  
differences	  seen	  in	  recovery	  between	  C57	  and	  Balb/C	  mice,	  the	  issue	  may	  be	  compounded	  by	  
differences	  in	  collateral	  density	  as	  well.	  
	   Collateral	  density	  provides	  a	  metric	  for	  the	  number	  of	  alternate	  paths	  blood	  can	  travel	  
to	  reach	  tissue.	  The	  greater	  the	  number	  of	  paths,	  the	  more	  likely	  flow	  will	  not	  be	  reduced	  to	  a	  
pathological	  level	  following	  an	  occlusive	  event	  [14].	  Balb/C	  mice	  have	  a	  lower	  collateral	  density	  
in	  the	  hind	  limb	  than	  C57’s,	  however	  whether	  collateral	  density	  is	  a	  major	  factor	  in	  chronic	  
recovery	  remains	  to	  be	  seen	  [15].	  One	  method	  of	  indirectly	  measuring	  the	  role	  of	  collateral	  
density	  in	  flow	  recovery	  would	  be	  to	  stimulate	  arteriogenesis	  in	  the	  gracilis	  muscle,	  and	  observe	  
its	  effect	  on	  downstream	  perfusion	  in	  the	  gastrocnemius.	  If	  flow	  were	  greatly	  restored,	  it	  would	  
suggest	  that	  collateral	  density	  does	  not	  play	  a	  major	  role	  in	  perfusion	  restoration,	  and	  the	  only	  a	  
small	  number	  of	  primary	  collaterals	  are	  needed	  to	  enlarge.	  
	   A	  limitation	  of	  this	  pilot	  study	  is	  the	  low	  number	  of	  replicates	  used	  (n=3).	  Although	  all	  
mice	  exhibited	  collateral	  vessels,	  a	  greater	  number	  of	  replicates	  is	  needed	  to	  increase	  
confidence	  in	  the	  results.	  Additionally,	  one	  replicate	  was	  excluded	  from	  the	  analysis	  due	  to	  poor	  
visualization	  of	  the	  stain.	  
	   As	  seen	  throughout	  this	  paper,	  the	  ability	  to	  measure	  blood	  flow	  is	  vital	  to	  
understanding	  recovery	  from	  an	  occlusive	  event.	  The	  lectin	  perfusion	  stain	  is	  an	  experimental	  
technique	  that	  provides	  network-­‐wide	  visualization	  of	  perfused	  regions	  of	  tissue	  at	  a	  given	  time	  
and	  a	  protocol	  was	  successfully	  adapted	  from	  Gabhann	  et	  al.	  for	  use	  in	  this	  project.	  A	  critical	  
step	  in	  ensuring	  the	  effectiveness	  of	  this	  process	  is	  to	  remove	  as	  much	  blood	  from	  the	  tissue	  as	  
possible,	  accomplished	  in	  this	  protocol	  using	  perfusion	  fixation,	  as	  blood	  has	  a	  strong	  
autofluorescence	  that	  greatly	  increases	  the	  amount	  of	  noise	  in	  fluorescence	  microscopy.	  This	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technique	  has	  strong	  potential	  for	  measuring	  the	  change	  in	  perfused	  area	  of	  a	  tissue	  over	  time	  
in	  the	  spinotrapezius,	  and	  possible	  applications	  in	  the	  gracilis	  muscle	  if	  properly	  adapted.	  
	   In	  summary,	  the	  pilot	  study	  and	  development	  of	  the	  lectin	  perfusion	  stain	  were	  
designed	  to	  further	  investigate	  the	  role	  of	  the	  vascular	  architecture	  in	  the	  healing	  response	  
following	  an	  occlusive	  event.	  The	  pilot	  study	  specifically	  focused	  on	  characterizing	  the	  network	  
topology	  of	  the	  gracilis	  muscle	  in	  Balb/C	  mice.	  The	  lectin	  perfusion	  stain	  was	  adapted	  for	  use	  in	  
the	  spinotrapezius	  for	  use	  in	  future	  studies.	  This	  research	  will	  hopefully	  lead	  to	  therapies	  that	  fill	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   Using	  the	  FV10-­‐ASW	  version	  4.1	  software,	  an	  outline	  of	  the	  muscle	  area	  in	  the	  x-­‐
y	  plane	  was	  described.	  Next,	  the	  thickness	  of	  the	  muscle	  (z-­‐direction)	  was	  described	  by	  
setting	  z-­‐min	  to	  the	  bottom	  of	  the	  visible	  muscle	  and	  z-­‐max	  to	  the	  top	  of	  the	  visible	  
muscle.	  The	  automated	  image	  capture	  program	  was	  then	  initiated.	  The	  program	  
automatically	  merged	  pictures	  in	  each	  x-­‐y	  plane	  together.	  The	  collective	  merged	  images	  
then	  formed	  a	  z-­‐stack,	  each	  describing	  a	  discrete	  level	  in	  the	  z-­‐axis.	  Two-­‐dimensional	  
images	  of	  the	  network	  were	  produced	  by	  averaging	  the	  z-­‐stack	  of	  images	  using	  the	  























	   A	  z-­‐project	  was	  then	  created,	  and	  the	  sum	  feature	  was	  used	  to	  merge	  the	  images	  












Troubleshooting	  the	  Lectin	  Perfusion	  Stain	  
	   Adapting	  the	  lectin	  perfusion	  staining	  protocol	  for	  use	  in	  the	  gracilis	  presented	  a	  
series	  of	  challenges.	  The	  first	  challenge	  resulted	  from	  the	  autofluoresence	  of	  blood	  
occurring	  within	  the	  same	  band	  of	  wavelength	  as	  the	  lectin	  stain	  used,	  drowning	  out	  the	  
signal	  from	  the	  lectin.	  Performing	  a	  perfusion	  fixation	  in	  place	  of	  in	  situ	  fixation	  
mitigated	  this	  problem.	  	  
	   The	  next	  challenge	  was	  capturing	  a	  clear	  image	  of	  the	  stain.	  Using	  the	  widefield	  
fluorescent	  microscope	  provided	  sharper	  resolution	  when	  viewed	  through	  the	  lenses,	  
however	  image	  quality	  was	  an	  issue	  when	  using	  the	  attached	  camera.	  After	  trying	  to	  
adjust	  the	  gain,	  autofocus,	  and	  brightness	  with	  little	  success	  the	  imaging	  was	  moved	  to	  
the	  confocal	  microscope.	  Here	  initial	  results	  were	  promising,	  however	  they	  were	  later	  
discarded	  when	  it	  was	  found	  using	  gain	  at	  90%	  cuts	  out	  most	  of	  the	  data,	  and	  the	  data	  
that	  remains	  becomes	  indistinguishable	  from	  noise,	  possibly	  creating	  an	  inaccurate	  
visual	  description	  of	  the	  vessels.	  Gain	  levels	  below	  10%	  were	  recommended.	  	  
	   Originally	  a	  single	  plane	  was	  used	  to	  capture	  the	  images,	  however	  this	  resulted	  
in	  a	  loss	  of	  clarity	  as	  vessels	  would	  appear	  and	  disappear	  due	  to	  the	  3D	  nature	  of	  the	  
subject.	  This	  third	  dimension	  of	  the	  muscle	  was	  better	  captured	  by	  taking	  pictures	  at	  
different	  heights	  throughout	  the	  thickness	  of	  the	  muscle.	  This	  introduced	  the	  
complication	  of	  merging	  the	  planes	  into	  a	  2D	  image	  or	  building	  a	  3D	  model	  of	  the	  vessel.	  
Building	  a	  3D	  image	  of	  the	  vessel	  proved	  to	  be	  beyond	  the	  scope	  and	  timeframe	  of	  the	  
project,	  as	  it	  was	  intensive	  in	  both	  the	  amount	  of	  time	  it	  took	  to	  capture	  the	  data	  and	  
effort	  needed	  to	  analyze	  it.	  	  
	   Deciding	  how	  to	  merge	  the	  planes	  required	  two	  decisions.	  First	  was	  the	  number	  
of	  “slices”	  the	  camera	  would	  take	  in	  the	  z-­‐direction,	  to	  capture	  the	  thickness	  of	  the	  
vessel.	  Take	  too	  many	  images	  and	  the	  noise	  from	  all	  of	  the	  images	  begins	  to	  combine	  
and	  drown	  out	  the	  useful	  date.	  Take	  too	  few	  and	  there	  is	  a	  risk	  of	  missing	  critical	  vessel	  
structures.	  Through	  trial	  and	  error	  a	  number	  of	  10	  slices	  was	  established,	  as	  it	  
represented	  a	  good	  balance	  of	  time	  spent	  imaging	  to	  quality	  of	  the	  images.	  The	  second	  
decision	  was	  how	  to	  merge	  the	  images	  from	  the	  different	  planes,	  which	  required	  some	  
amount	  of	  manipulation	  of	  the	  images.	  The	  ImageJ	  software	  provided	  different	  options	  
such	  as	  Average,	  Max,	  Min,	  and	  Sum	  slices	  to	  combine	  the	  stack	  of	  images.	  The	  Average	  
function	  was	  chosen	  as	  it	  helped	  clarify	  vessels	  while	  not	  dramatically	  increasing	  the	  
amount	  of	  noise.	  	  Functions	  such	  as	  Max	  and	  Sum	  tended	  to	  produce	  over	  saturated	  
images	  that	  lost	  clarity.	  Overall	  muscle	  clarity	  still	  needs	  to	  be	  improved,	  as	  only	  
sections	  of	  the	  muscle	  were	  clearly	  visible	  with	  the	  stain.	  This	  is	  likely	  due	  to	  the	  3D	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nature	  of	  the	  muscle	  and	  can	  be	  dealt	  with	  by	  optimizing	  the	  image	  capturing	  
techniques	  used	  with	  the	  confocal	  microscope.	  
